Aveanna Healthcare Holdings Inc (AVAH)
NASDAQ:AVAH
Want to see AVAH full AI Analyst Report?
AVAH Stock Chart & Stats
$6.77
$0.12(2.70%)
At close: 4:00 PM EST
$6.77
$0.12(2.70%)
Day’s Range― - ―
52-Week Range$3.73 - $10.32
Previous CloseN/A
Volume95.00K
Average Volume (3M)1.18M
Market Cap
$1.47B
Enterprise Value$2.62B
Total Cash (Recent Filing)$193.26M
Total Debt (Recent Filing)$1.34B
Price to Earnings (P/E)2.3
Beta1.24
Next Earnings
May 14, 2026EPS Estimate
0.13Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.11
Shares Outstanding217,510,040
10 Day Avg. Volume1,175,338
30 Day Avg. Volume1,180,792
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)8.46
Price to Sales (P/S)0.68
P/FCF Ratio14.33
Enterprise Value/Market Cap1.78
Enterprise Value/Revenue1.08
Enterprise Value/Gross Profit3.25
Enterprise Value/Ebitda9.53
Forecast
1Y Price Target
$9.26Price Target Upside36.76% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering8
EPS Forecast (FY)0.62
Revenue Forecast (FY)$2.56B
Bulls Say, Bears Say
Bulls Say
Conservative Guidance Provides UpsideManagement maintained revenue and EBITDA guidance without assuming contribution from the pending acquisition, indicating a conservative stance that could leave upside if the deal contributes after closing.
Growth OutlookAnalyst notes the company is moving into a phase of normalization with stable organic growth after strategic transformation, supporting expectations for steadier revenue trends.
Strategic Acquisition ExpansionAcquisition of Family First Homecare increases presence in pediatric private duty services and builds market density in Florida, strengthening revenue diversification in core services.
Bears Say
Acquisition Disclosure UncertaintyNo financial disclosures were provided for the acquisition target, creating uncertainty around the deal's true earnings contribution and financial impact.
One-time Items Inflating ResultsQuarterly results benefited from a one-time revenue reserve release and an extra week in the fiscal calendar, suggesting reported margins and profitability may be higher than normalized levels.
Rising Leverage Risk From Deal FinancingPlan to fund the transaction with cash on hand and the existing credit facility could increase balance sheet leverage, which may heighten investor concern about financial flexibility.
Aveanna Healthcare Holdings News
AVAH FAQ
What was Aveanna Healthcare Holdings Inc’s price range in the past 12 months?
Aveanna Healthcare Holdings Inc lowest stock price was $3.73 and its highest was $10.32 in the past 12 months.
What is Aveanna Healthcare Holdings Inc’s market cap?
Aveanna Healthcare Holdings Inc’s market cap is $1.47B.
When is Aveanna Healthcare Holdings Inc’s upcoming earnings report date?
Aveanna Healthcare Holdings Inc’s upcoming earnings report date is May 14, 2026 which is in 4 days.
How were Aveanna Healthcare Holdings Inc’s earnings last quarter?
Aveanna Healthcare Holdings Inc released its earnings results on Mar 19, 2026. The company reported $0.17 earnings per share for the quarter, beating the consensus estimate of $0.154 by $0.016.
Is Aveanna Healthcare Holdings Inc overvalued?
According to Wall Street analysts Aveanna Healthcare Holdings Inc’s price is currently Undervalued.
Does Aveanna Healthcare Holdings Inc pay dividends?
Aveanna Healthcare Holdings Inc does not currently pay dividends.
What is Aveanna Healthcare Holdings Inc’s EPS estimate?
Aveanna Healthcare Holdings Inc’s EPS estimate is 0.13.
How many shares outstanding does Aveanna Healthcare Holdings Inc have?
Aveanna Healthcare Holdings Inc has 217,510,040 shares outstanding.
What happened to Aveanna Healthcare Holdings Inc’s price movement after its last earnings report?
Aveanna Healthcare Holdings Inc reported an EPS of $0.17 in its last earnings report, beating expectations of $0.154. Following the earnings report the stock price went down -8.249%.
Which hedge fund is a major shareholder of Aveanna Healthcare Holdings Inc?
Currently, no hedge funds are holding shares in AVAH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Aveanna Healthcare Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$9.26 (36.76% Upside)
$9.26 (36.76% Upside)
Blogger Sentiment
Bullish
AVAH Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 1.1M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▼ 3.4%
Last 30 Days ▲ 22.0%
Last 30 Days ▲ 22.0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
49.11%
12-Months-Change
Fundamentals
Return on Equity
953.09%
Trailing 12-Months
Asset Growth
20.54%
Trailing 12-Months
Company Description
Aveanna Healthcare Holdings Inc
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides private duty nursing (PDN), adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the United States. Its patient- centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based pediatric therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.
AVAH Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented strong operational and financial momentum: double-digit top-line growth, substantial YoY adjusted EBITDA expansion, improved margins in key segments, robust liquidity and free cash flow, and meaningful progress on preferred payer strategies and targeted M&A (Family First). Offsetting risks include non-recurring benefits (53rd week and reserve release), continued caregiver labor and wage pressure, California reimbursement uncertainty, Medical Solutions near-term normalization, and material variable-rate debt (largely hedged). Management provided prudent 2026 guidance that normalizes the strong 2025 results and emphasized continued execution on preferred payer expansion, margin stabilization, and selective acquisitions.View all AVAH earnings summariesAVAH Stock 12 Month Forecast
Average Price Target
$9.26
▲(36.76% Upside)
Technical Analysis
Addus Homecare
―
Brookdale Senior Living
―
National Healthcare
―
Select Medical
―
Pennant Group
―
Ownership Overview
57.69% Insiders
6.20% Mutual Funds
21.54% Other Institutional Investors
9.99% Public Companies and
Individual Investors